| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/AJRCCM.165.4.2012112 |
| P698 | PubMed publication ID | 11850348 |
| P50 | author | Ingrid Durand-Gasselin | Q116793554 |
| Marc Humbert | Q33113039 | ||
| Peter Dorfmuller | Q37842237 | ||
| Karl Balabanian | Q47976012 | ||
| Gilles Garcia | Q87774022 | ||
| Gérald Simonneau | Q98151102 | ||
| Anne Marfaing-Koka | Q114426332 | ||
| Fréderique Capron | Q114718328 | ||
| Dominique Emilie | Q114782226 | ||
| P2093 | author name string | Véronique Zarka | |
| Gianpaola Monti | |||
| Aurore Coulomb-Lherminé | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arterial hypertension | Q41861 |
| P304 | page(s) | 534-539 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Chemokine RANTES in severe pulmonary arterial hypertension | |
| P478 | volume | 165 |
| Q92263764 | Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension |
| Q34250971 | Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension |
| Q30945205 | Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease |
| Q54355810 | Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats. |
| Q39405856 | Anti-endothelial cell antibodies in connective tissue diseases associated with pulmonary arterial hypertension |
| Q49644763 | CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation. |
| Q87304211 | CCL5 upregulates IL-10 expression and partially mediates the antihypertensive effects of IL-10 in the vascular smooth muscle cells of spontaneously hypertensive rats |
| Q42020850 | CCR5 as a treatment target in pulmonary arterial hypertension |
| Q33917277 | CXC-chemokine ligand 10 in idiopathic pulmonary arterial hypertension: marker of improved survival |
| Q34672038 | Chemokine receptor CCR5: from AIDS to atherosclerosis |
| Q35055460 | Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2002. |
| Q61811653 | Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension |
| Q35779717 | Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells |
| Q42635527 | Downregulation of Angiotensin II-Induced 12-Lipoxygenase Expression and Cell Proliferation in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats by CCL5 |
| Q47700134 | Emerging Therapeutics in Pulmonary Hypertension |
| Q37209074 | Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. |
| Q35684753 | Endothelin-1, the unfolded protein response, and persistent inflammation: role of pulmonary artery smooth muscle cells |
| Q45103953 | Fas/FasL and perforin/granzyme pathway in acute rejection and diffuse alveolar damage after allogeneic lung transplantation-a human biopsy study |
| Q35571972 | High-mobility group box-1 induces vascular remodelling processes via c-Jun activation |
| Q33764751 | Hypoxia-induced mitogenic factor (FIZZ1/RELMα) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertension |
| Q35184983 | Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling |
| Q34913082 | Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction |
| Q26851508 | Immune and inflammatory mechanisms in pulmonary arterial hypertension |
| Q42273111 | Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice |
| Q35289907 | Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension. |
| Q52685710 | Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series). |
| Q33898213 | Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension |
| Q27007510 | Inflammatory cytokines in pulmonary hypertension |
| Q38111730 | Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension |
| Q35572413 | Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice |
| Q34897476 | Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension? |
| Q61895140 | Les voies de recherche |
| Q49996636 | Lung Function, Inflammation, and Endothelin-1 in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension |
| Q26778504 | Maraviroc: a review of its use in HIV infection and beyond |
| Q37892336 | Mechanisms of disease: pulmonary arterial hypertension. |
| Q59352387 | Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV Infection |
| Q33786092 | N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats |
| Q33982467 | New trial designs and potential therapies for pulmonary artery hypertension |
| Q37669139 | Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension |
| Q37215728 | Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. |
| Q38601788 | Origin and production of inflammatory perivascular macrophages in pulmonary hypertension |
| Q37689190 | PPARgamma as a potential therapeutic target in pulmonary hypertension |
| Q35235680 | Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner |
| Q36447388 | Pathogenic mechanisms of pulmonary arterial hypertension |
| Q56388717 | Pathology of pulmonary hypertension |
| Q37879213 | Pediatric pulmonary arterial hypertension: current and emerging therapeutic options |
| Q35412268 | Progenitor cells in pulmonary vascular remodeling |
| Q40178749 | Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension |
| Q89860088 | Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective |
| Q92924608 | Pulmonary Hypertension Remodels the Genomic Fabrics of Major Functional Pathways |
| Q59303969 | Pulmonary arterial hypertension |
| Q52355584 | Pulmonary arterial hypertension: pathogenesis and clinical management. |
| Q35766646 | Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis |
| Q37773387 | Pulmonary vascular disease associated with parasitic infection--the role of schistosomiasis |
| Q27687091 | Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation |
| Q37532988 | Reactive oxygen species in pulmonary vascular remodeling |
| Q97538437 | Relationship between compliance and pulmonary vascular resistance in pulmonary arterial hypertension |
| Q79501935 | Serum monocyte chemotactic protein-1 levels in congenital diaphragmatic hernia |
| Q36568847 | Sildenafil Reduces Inflammation and Prevents Pulmonary Arterial Remodeling of the Monocrotaline - induced Disease in the Wistar Rats. |
| Q38112038 | Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension |
| Q33679052 | T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension |
| Q91653814 | The Search for Disease-Modifying Therapies in Pulmonary Hypertension |
| Q49681135 | The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension. |
| Q35564266 | The role of chemokines in the pathogenesis of scleroderma |
| Q33478462 | Thromboembolism and pulmonary hypertension |
| Q42154373 | Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells |
| Q40863905 | Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration |
| Q61895220 | Vaskulopathien bei pulmonal-arterieller Hypertonie |
| Q84393114 | [Etiopathogenesis and physiopathology in chronic thromboembolic pulmonary hypertension] |
Search more.